output stringlengths 5 24.3k | instruction stringlengths 33 308 | system stringclasses 1 value |
|---|---|---|
1. Bronchodilator Agents [adverse effects, *therapeutic use]; 2. Forced Expiratory Volume; 3. Ipratropium [adverse effects, *therapeutic use]; 4. Pulmonary Disease, Chronic Obstructive [*drug therapy]; 5. Randomized Controlled Trials as Topic; 6. Scopolamine Derivatives [adverse effects, *therapeutic use]; 7. Tiotropium Bromide [adverse effects, *therapeutic use]; | Provide MESH terms for the study
Tiotropium versus ipratropium bromide for chronic obstructive pulmonary disease | You are a research assistant. Based on the question please provide appropriate answers |
1. Administration, Inhalation; 2. Adrenal Cortex Hormones [*administration & dosage, adverse effects]; 3. Anti‐Asthmatic Agents [*administration & dosage, adverse effects]; 4. Asthma [*drug therapy]; 5. Disease Progression; 6. Drug Therapy, Combination [methods]; 7. Muscarinic Antagonists [*administration & dosage, adverse effects]; 8. Quality of Life; 9. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Long‐acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus the same dose of ICS alone for adults with asthma | You are a research assistant. Based on the question please provide appropriate answers |
1. Cerebral Hemorrhage [chemically induced]; 2. Drug Combinations; 3. Enterocolitis, Necrotizing [chemically induced]; 4. Fatty Alcohols [therapeutic use]; 5. Infant, Premature; 6. Polyethylene Glycols [therapeutic use]; 7. Pulmonary Surfactants [adverse effects, *therapeutic use]; 8. Randomized Controlled Trials as Topic; 9. Respiratory Distress Syndrome, Newborn [*drug therapy, *prevention & control]; | Provide MESH terms for the study
Animal derived surfactant extract versus protein free synthetic surfactant for the prevention and treatment of respiratory distress syndrome | You are a research assistant. Based on the question please provide appropriate answers |
1. Anti‐Bacterial Agents [*administration & dosage, adverse effects]; 2. Bronchiectasis [*drug therapy, microbiology]; 3. Diarrhea [chemically induced]; 4. Disease Progression; 5. Drug Resistance, Bacterial; 6. Hospitalization [statistics & numerical data]; 7. Odds Ratio; 8. Randomized Controlled Trials as Topic; 9. Time Factors; | Provide MESH terms for the study
Prolonged antibiotics for non‐cystic fibrosis bronchiectasis in children and adults | You are a research assistant. Based on the question please provide appropriate answers |
1. Administration, Inhalation; 2. Administration, Oral; 3. Adrenal Cortex Hormones [*administration & dosage, adverse effects]; 4. Anti‐Asthmatic Agents [*administration & dosage, adverse effects]; 5. Asthma [*drug therapy]; 6. Disease Progression; 7. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Intermittent inhaled corticosteroid therapy versus placebo for persistent asthma in children and adults | You are a research assistant. Based on the question please provide appropriate answers |
1. Administration, Inhalation; 2. Adrenal Cortex Hormones [*administration & dosage]; 3. Anti‐Asthmatic Agents [administration & dosage]; 4. Asthma [*drug therapy]; 5. Beclomethasone [administration & dosage]; 6. Cross‐Over Studies; 7. Muscarinic Antagonists [*administration & dosage]; 8. Randomized Controlled Trials as Topic; 9. Tiotropium Bromide [administration & dosage]; | Provide MESH terms for the study
Long‐acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus higher dose ICS for adults with asthma | You are a research assistant. Based on the question please provide appropriate answers |
1. Analgesics, Opioid [administration & dosage, *adverse effects]; 2. Apnea [chemically induced, diagnosis]; 3. Benzodiazepines [administration & dosage, adverse effects]; 4. Disease Progression; 5. Hypnotics and Sedatives [administration & dosage, *adverse effects]; 6. Oxygen Consumption [drug effects]; 7. Randomized Controlled Trials as Topic; 8. Sleep Apnea, Obstructive [*chemically induced]; | Provide MESH terms for the study
Effects of opioid, hypnotic and sedating medications on sleep‐disordered breathing in adults with obstructive sleep apnoea | You are a research assistant. Based on the question please provide appropriate answers |
1. *Withholding Treatment; 2. Administration, Inhalation; 3. Adrenal Cortex Hormones [administration & dosage]; 4. Adrenergic beta‐2 Receptor Agonists [*administration & dosage]; 5. Anti‐Asthmatic Agents [*administration & dosage]; 6. Asthma [*drug therapy]; 7. Randomized Controlled Trials as Topic; 8. Time Factors; | Provide MESH terms for the study
Stopping long‐acting beta2‐agonists (LABA) for adults with asthma well controlled by LABA and inhaled corticosteroids | You are a research assistant. Based on the question please provide appropriate answers |
1. Administration, Inhalation; 2. Adrenal Cortex Hormones [*administration & dosage]; 3. Adrenergic beta‐2 Receptor Agonists [*administration & dosage]; 4. Asthma [*drug therapy]; 5. Double‐Blind Method; 6. Drug Therapy, Combination [methods]; 7. Muscarinic Antagonists [*administration & dosage]; 8. Quality of Life; 9. Randomized Controlled Trials as Topic; 10. Salmeterol Xinafoate [administration & dosage]; 11. Tiotropium Bromide [administration & dosage]; | Provide MESH terms for the study
Long‐acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus addition of long‐acting beta2‐agonists (LABA) for adults with asthma | You are a research assistant. Based on the question please provide appropriate answers |
1. *Withholding Treatment; 2. Administration, Inhalation; 3. Adrenal Cortex Hormones [*administration & dosage]; 4. Adrenergic beta‐2 Receptor Agonists [*administration & dosage]; 5. Asthma [*drug therapy]; | Provide MESH terms for the study
Stopping long‐acting beta2‐agonists (LABA) for children with asthma well controlled on LABA and inhaled corticosteroids | You are a research assistant. Based on the question please provide appropriate answers |
1. *Exercise Tolerance; 2. *Health Status; 3. *Quality of Life; 4. Dyspnea [rehabilitation]; 5. Pulmonary Disease, Chronic Obstructive [psychology, *rehabilitation]; 6. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Pulmonary rehabilitation for chronic obstructive pulmonary disease | You are a research assistant. Based on the question please provide appropriate answers |
1. Acute Lung Injury [*complications, mortality]; 2. Critical Care; 3. Hospital Mortality; 4. Pressure; 5. Randomized Controlled Trials as Topic; 6. Respiration, Artificial [adverse effects, *methods, mortality]; 7. Respiratory Distress Syndrome [*complications, mortality]; 8. Respiratory Insufficiency [etiology, mortality, *therapy]; 9. Selection Bias; | Provide MESH terms for the study
Pressure‐controlled versus volume‐controlled ventilation for acute respiratory failure due to acute lung injury (ALI) or acute respiratory distress syndrome (ARDS) | You are a research assistant. Based on the question please provide appropriate answers |
1. Critical Care [*methods]; 2. Critical Illness [mortality, *therapy]; 3. Length of Stay [statistics & numerical data]; 4. Pneumonia [mortality]; 5. Randomized Controlled Trials as Topic; 6. Respiration, Artificial [statistics & numerical data]; 7. Time Factors; 8. Tracheostomy [adverse effects, *methods, mortality]; | Provide MESH terms for the study
Early versus late tracheostomy for critically ill patients | You are a research assistant. Based on the question please provide appropriate answers |
1. Adrenergic beta‐2 Receptor Agonists [*administration & dosage]; 2. Drug Administration Schedule; 3. Forced Expiratory Volume [physiology]; 4. Formoterol Fumarate [administration & dosage]; 5. Indans [*administration & dosage]; 6. Pulmonary Disease, Chronic Obstructive [drug therapy]; 7. Quinolones [*administration & dosage]; 8. Randomized Controlled Trials as Topic; 9. Salmeterol Xinafoate [administration & dosage]; | Provide MESH terms for the study
Indacaterol, a once‐daily beta2‐agonist, versus twice‐daily beta2‐agonists or placebo for chronic obstructive pulmonary disease | You are a research assistant. Based on the question please provide appropriate answers |
1. *Critical Illness; 2. Adrenergic alpha‐2 Receptor Agonists [adverse effects, *therapeutic use]; 3. Bradycardia [chemically induced]; 4. Clonidine [therapeutic use]; 5. Conscious Sedation [*methods]; 6. Dexmedetomidine [adverse effects, *therapeutic use]; 7. Lorazepam [adverse effects, therapeutic use]; 8. Midazolam [adverse effects, therapeutic use]; 9. Propofol [adverse effects, therapeutic use]; 10. Randomized Controlled Trials as Topic; 11. Respiration, Artificial [*statistics & numerical data]; 12. Selection Bias; 13. Time Factors; | Provide MESH terms for the study
Alpha‐2 agonists for long‐term sedation during mechanical ventilation in critically ill patients | You are a research assistant. Based on the question please provide appropriate answers |
1. Bronchopulmonary Dysplasia [mortality, *prevention & control]; 2. Gestational Age; 3. Infant, Premature; 4. Infant, Premature, Diseases [mortality, *prevention & control]; 5. Pentoxifylline [*therapeutic use]; 6. Phosphodiesterase Inhibitors [*therapeutic use]; 7. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Pentoxifylline for the prevention of bronchopulmonary dysplasia in preterm infants | You are a research assistant. Based on the question please provide appropriate answers |
1. Adrenergic beta‐2 Receptor Agonists [therapeutic use]; 2. Bronchodilator Agents [*therapeutic use]; 3. Disease Progression; 4. Muscarinic Antagonists [*therapeutic use]; 5. Pulmonary Disease, Chronic Obstructive [*drug therapy]; 6. Randomized Controlled Trials as Topic; 7. Scopolamine Derivatives [therapeutic use]; 8. Tiotropium Bromide; 9. Tropanes [*therapeutic use]; | Provide MESH terms for the study
Aclidinium bromide for stable chronic obstructive pulmonary disease | You are a research assistant. Based on the question please provide appropriate answers |
1. *Critical Illness; 2. *Ventilators, Mechanical [adverse effects]; 3. Automation [*instrumentation]; 4. Intensive Care Units; 5. Length of Stay; 6. Randomized Controlled Trials as Topic; 7. Time Factors; 8. Ventilator Weaning [*instrumentation, *methods]; 9. Work of Breathing; | Provide MESH terms for the study
Automated weaning and SBT systems versus non‐automated weaning strategies for weaning time in invasively ventilated critically ill adults | You are a research assistant. Based on the question please provide appropriate answers |
1. Acute Disease; 2. Administration, Oral; 3. Disease Progression; 4. Glucocorticoids [*administration & dosage, adverse effects]; 5. Infusions, Intravenous; 6. Pulmonary Disease, Chronic Obstructive [*drug therapy]; 7. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease | You are a research assistant. Based on the question please provide appropriate answers |
1. *Continuous Positive Airway Pressure; 2. Abdomen [*surgery]; 3. Cause of Death; 4. Hypoxia [prevention & control]; 5. Intensive Care Units; 6. Laparotomy; 7. Length of Stay; 8. Pneumonia [*prevention & control]; 9. Postoperative Complications [mortality, *prevention & control]; 10. Postoperative Period; 11. Pulmonary Atelectasis [*prevention & control]; 12. Randomized Controlled Trials as Topic; 13. Retreatment [statistics & numerical data]; | Provide MESH terms for the study
Continuous positive airway pressure (CPAP) during the postoperative period for prevention of postoperative morbidity and mortality following major abdominal surgery | You are a research assistant. Based on the question please provide appropriate answers |
1. Acute Disease; 2. Administration, Inhalation; 3. Adrenergic beta‐2 Receptor Agonists [*administration & dosage]; 4. Anti‐Asthmatic Agents [*administration & dosage]; 5. Asthma [*drug therapy]; 6. Cholinergic Antagonists [*administration & dosage]; 7. Drug Administration Schedule; 8. Drug Therapy, Combination; 9. Hospitalization; 10. Ipratropium [administration & dosage]; 11. Nebulizers and Vaporizers; 12. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Inhaled anticholinergics and short‐acting beta2‐agonists versus short‐acting beta2‐agonists alone for children with acute asthma in hospital | You are a research assistant. Based on the question please provide appropriate answers |
1. Bronchodilator Agents [*therapeutic use]; 2. Cholinergic Antagonists [*therapeutic use]; 3. Disease Progression; 4. Dry Powder Inhalers; 5. Nebulizers and Vaporizers; 6. Placebo Effect; 7. Pulmonary Disease, Chronic Obstructive [*drug therapy]; 8. Quality of Life; 9. Randomized Controlled Trials as Topic; 10. Scopolamine Derivatives [*therapeutic use]; 11. Tiotropium Bromide; | Provide MESH terms for the study
Tiotropium versus placebo for chronic obstructive pulmonary disease | You are a research assistant. Based on the question please provide appropriate answers |
1. *Gymnastics; 2. *Swimming; 3. *Water; 4. Anti‐Asthmatic Agents [therapeutic use]; 5. Asthma [*therapy]; 6. Randomized Controlled Trials as Topic; 7. Resistance Training [*methods]; | Provide MESH terms for the study
Water‐based exercise for adults with asthma | You are a research assistant. Based on the question please provide appropriate answers |
1. Administration, Inhalation; 2. Adrenal Cortex Hormones [administration & dosage, *adverse effects]; 3. Androstadienes [administration & dosage, adverse effects]; 4. Anti‐Asthmatic Agents [administration & dosage, *adverse effects]; 5. Asthma [*drug therapy]; 6. Beclomethasone [administration & dosage, adverse effects]; 7. Budesonide [administration & dosage, adverse effects]; 8. Fluocinolone Acetonide [administration & dosage, adverse effects, analogs & derivatives]; 9. Fluticasone; 10. Growth [*drug effects]; 11. Growth Disorders [*chemically induced]; 12. Mometasone Furoate; 13. Patient Dropouts [statistics & numerical data]; 14. Pregnadienediols [administration & dosage, adverse effects]; 15. Pregnenediones [administration & dosage, adverse effects]; | Provide MESH terms for the study
Inhaled corticosteroids in children with persistent asthma: effects on growth | You are a research assistant. Based on the question please provide appropriate answers |
1. Administration, Inhalation; 2. Adrenal Cortex Hormones [*administration & dosage, adverse effects]; 3. Androstadienes [administration & dosage, adverse effects]; 4. Anti‐Asthmatic Agents [*administration & dosage, adverse effects]; 5. Asthma [*drug therapy]; 6. Beclomethasone [administration & dosage, adverse effects]; 7. Budesonide [administration & dosage, adverse effects]; 8. Dose‐Response Relationship, Drug; 9. Fluticasone; 10. Growth [*drug effects]; 11. Growth Disorders [*chemically induced]; 12. Mometasone Furoate; 13. Pregnadienediols [administration & dosage, adverse effects]; 14. Pregnenediones [administration & dosage, adverse effects]; 15. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Inhaled corticosteroids in children with persistent asthma: dose‐response effects on growth | You are a research assistant. Based on the question please provide appropriate answers |
1. Ambulatory Care; 2. Exercise [physiology]; 3. Hypoxia [therapy]; 4. Oxygen Inhalation Therapy [*methods]; 5. Pulmonary Disease, Chronic Obstructive [blood, physiopathology, *therapy]; 6. Randomized Controlled Trials as Topic; 7. Rest; | Provide MESH terms for the study
Ambulatory oxygen for people with chronic obstructive pulmonary disease who are not hypoxaemic at rest | You are a research assistant. Based on the question please provide appropriate answers |
1. Administration, Inhalation; 2. Adrenal Cortex Hormones [*administration & dosage]; 3. Adrenergic beta‐2 Receptor Agonists [*administration & dosage]; 4. Bronchiectasis [*drug therapy]; 5. Budesonide [administration & dosage]; 6. Disease Progression; 7. Drug Therapy, Combination [methods]; 8. Ethanolamines [administration & dosage]; 9. Formoterol Fumarate; 10. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Combination inhaled corticosteroids and long‐acting beta2‐agonists for children and adults with bronchiectasis | You are a research assistant. Based on the question please provide appropriate answers |
1. *Emergency Service, Hospital; 2. Anti‐Asthmatic Agents [*administration & dosage, adverse effects]; 3. Asthma [*drug therapy]; 4. Hospitalization [statistics & numerical data]; 5. Infusions, Intravenous [methods]; 6. Magnesium Sulfate [*administration & dosage, adverse effects]; 7. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Intravenous magnesium sulfate for treating adults with acute asthma in the emergency department | You are a research assistant. Based on the question please provide appropriate answers |
1. *Disclosure; 2. *Writing; 3. Asthma [*psychology, therapy]; 4. Forced Expiratory Volume; 5. Psychotherapy [*methods]; 6. Randomized Controlled Trials as Topic; 7. Stress, Psychological [*therapy]; | Provide MESH terms for the study
Written emotional disclosure for asthma | You are a research assistant. Based on the question please provide appropriate answers |
1. *Noninvasive Ventilation; 2. Exercise Tolerance [*physiology]; 3. Forced Expiratory Volume [physiology]; 4. Physical Conditioning, Human [*methods, physiology]; 5. Pulmonary Disease, Chronic Obstructive [physiopathology, *rehabilitation]; 6. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Non‐invasive ventilation during exercise training for people with chronic obstructive pulmonary disease | You are a research assistant. Based on the question please provide appropriate answers |
1. Anti‐Bacterial Agents [therapeutic use]; 2. Bromhexine [therapeutic use]; 3. Bronchiectasis [*therapy]; 4. Deoxyribonucleases [therapeutic use]; 5. Drug Therapy, Combination; 6. Expectorants [*therapeutic use]; 7. Randomized Controlled Trials as Topic; 8. Recombinant Proteins [therapeutic use]; 9. Thioglycolates [therapeutic use]; 10. Thiophenes [therapeutic use]; | Provide MESH terms for the study
Mucolytics for bronchiectasis | You are a research assistant. Based on the question please provide appropriate answers |
1. Adrenal Cortex Hormones [therapeutic use]; 2. Adrenergic beta‐2 Receptor Agonists [therapeutic use]; 3. Cholinergic Antagonists [therapeutic use]; 4. DNA‐Binding Proteins; 5. Delayed‐Action Preparations [administration & dosage]; 6. Muscarinic Antagonists [therapeutic use]; 7. Nuclear Proteins; 8. Pulmonary Disease, Chronic Obstructive [*drug therapy]; 9. Randomized Controlled Trials as Topic; 10. Transcription Factors; | Provide MESH terms for the study
Long‐acting inhaled therapy (beta‐agonists, anticholinergics and steroids) for COPD: a network meta‐analysis | You are a research assistant. Based on the question please provide appropriate answers |
1. Administration, Inhalation; 2. Adrenergic beta‐2 Receptor Agonists [administration & dosage, adverse effects]; 3. Androstadienes [administration & dosage, *adverse effects]; 4. Anti‐Inflammatory Agents [administration & dosage, *adverse effects]; 5. Bronchodilator Agents [administration & dosage, *adverse effects]; 6. Budesonide [administration & dosage, *adverse effects]; 7. Drug Therapy, Combination [methods]; 8. Fluticasone; 9. Pneumonia [chemically induced]; 10. Pulmonary Disease, Chronic Obstructive [*drug therapy]; 11. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease | You are a research assistant. Based on the question please provide appropriate answers |
1. Adrenal Cortex Hormones [*therapeutic use]; 2. Adrenergic beta‐2 Receptor Agonists [*therapeutic use]; 3. Anti‐Asthmatic Agents [*therapeutic use]; 4. Asthma [*drug therapy]; 5. Chronic Disease; 6. Drug Therapy, Combination [methods]; 7. Leukotriene Antagonists [*therapeutic use]; 8. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Addition to inhaled corticosteroids of long‐acting beta2‐agonists versus anti‐leukotrienes for chronic asthma | You are a research assistant. Based on the question please provide appropriate answers |
1. Breathing Exercises [methods]; 2. Exercise Therapy [*methods]; 3. Exercise Tolerance; 4. Hydrotherapy [adverse effects, *methods]; 5. Pulmonary Disease, Chronic Obstructive [*rehabilitation]; 6. Quality of Life; 7. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Water‐based exercise training for chronic obstructive pulmonary disease | You are a research assistant. Based on the question please provide appropriate answers |
1. Anti‐Asthmatic Agents [*administration & dosage]; 2. Asthma [*drug therapy]; 3. Bronchodilator Agents [*administration & dosage]; 4. Budesonide [*administration & dosage]; 5. Drug Combinations; 6. Ethanolamines [*administration & dosage]; 7. Formoterol Fumarate; 8. Maintenance Chemotherapy [methods]; 9. Nebulizers and Vaporizers; 10. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Combination formoterol and budesonide as maintenance and reliever therapy versus combination inhaler maintenance for chronic asthma in adults and children | You are a research assistant. Based on the question please provide appropriate answers |
1. Noninvasive Ventilation [*methods]; 2. Pneumonia, Ventilator-Associated [prevention & control]; 3. Positive-Pressure Respiration [*methods, mortality]; 4. Pulmonary Disease, Chronic Obstructive [mortality, *therapy]; 5. Quality of Life; 6. Randomized Controlled Trials as Topic; 7. Respiratory Insufficiency [mortality, *therapy]; 8. Ventilator Weaning [*methods]; | Provide MESH terms for the study
Noninvasive positive‐pressure ventilation as a weaning strategy for intubated adults with respiratory failure | You are a research assistant. Based on the question please provide appropriate answers |
1. *Lung Transplantation; 2. Alemtuzumab; 3. Antibodies, Monoclonal [therapeutic use]; 4. Antibodies, Monoclonal, Humanized [therapeutic use]; 5. Antilymphocyte Serum [therapeutic use]; 6. Basiliximab; 7. Daclizumab; 8. Graft Rejection [immunology, *prevention & control]; 9. Immunoglobulin G [therapeutic use]; 10. Immunosuppression Therapy [adverse effects, *methods]; 11. Immunosuppressive Agents [adverse effects, *therapeutic use]; 12. Muromonab‐CD3 [therapeutic use]; 13. Randomized Controlled Trials as Topic; 14. Receptors, Interleukin‐2 [antagonists & inhibitors]; 15. Recombinant Fusion Proteins [therapeutic use]; 16. T‐Lymphocytes [*immunology]; | Provide MESH terms for the study
Antibody induction therapy for lung transplant recipients | You are a research assistant. Based on the question please provide appropriate answers |
1. Asthma [*therapy]; 2. *Cell Phone; 3. *Computers, Handheld; 4. *Mobile Applications; 5. Randomized Controlled Trials as Topic; 6. Self Care [instrumentation, *methods]; | Provide MESH terms for the study
Smartphone and tablet self management apps for asthma | You are a research assistant. Based on the question please provide appropriate answers |
1. Drug Therapy, Combination [methods]; 2. Glucocorticoids [*therapeutic use]; 3. Infant, Premature; 4. *Obstetric Labor, Premature; 5. Randomized Controlled Trials as Topic; 6. Respiratory Distress Syndrome, Newborn [*prevention & control]; 7. Thyrotropin-Releasing Hormone [adverse effects, *therapeutic use]; | Provide MESH terms for the study
Thyrotropin‐releasing hormone added to corticosteroids for women at risk of preterm birth for preventing neonatal respiratory disease | You are a research assistant. Based on the question please provide appropriate answers |
1. *Cesarean Section; 2. Preoperative Care [*methods]; 3. Prostaglandins E [*administration & dosage]; 4. Randomized Controlled Trials as Topic; 5. Respiratory Distress Syndrome, Newborn [*prevention & control]; | Provide MESH terms for the study
Prostaglandins before caesarean section for preventing neonatal respiratory distress | You are a research assistant. Based on the question please provide appropriate answers |
1. Adrenergic beta‐2 Receptor Agonists [*therapeutic use]; 2. Bronchodilator Agents [*therapeutic use]; 3. Drug Combinations; 4. Nebulizers and Vaporizers; 5. Pulmonary Disease, Chronic Obstructive [*drug therapy]; 6. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Combined corticosteroid and long‐acting beta2‐agonist in one inhaler versus placebo for chronic obstructive pulmonary disease | You are a research assistant. Based on the question please provide appropriate answers |
1. Administration, Inhalation; 2. Adrenergic beta-2 Receptor Agonists [*administration & dosage]; 3. Drug Administration Schedule; 4. Pulmonary Disease, Chronic Obstructive [drug therapy, mortality]; 5. Quality of Life; 6. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Long‐acting beta2‐agonists for chronic obstructive pulmonary disease | You are a research assistant. Based on the question please provide appropriate answers |
1. Adrenergic beta‐2 Receptor Agonists [*therapeutic use]; 2. Beclomethasone [*therapeutic use]; 3. Forced Expiratory Volume [drug effects, physiology]; 4. Glucocorticoids [*therapeutic use]; 5. Pulmonary Disease, Chronic Obstructive [*drug therapy]; 6. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Beclometasone for chronic obstructive pulmonary disease | You are a research assistant. Based on the question please provide appropriate answers |
1. Acetates [*administration & dosage]; 2. Asthma [*drug therapy]; 3. Cyclopropanes; 4. Drug Therapy, Combination [methods]; 5. Leukotriene Antagonists [*administration & dosage]; 6. Quinolines [*administration & dosage]; 7. Randomized Controlled Trials as Topic; 8. Sulfides; | Provide MESH terms for the study
Addition of anti‐leukotriene agents to inhaled corticosteroids in children with persistent asthma | You are a research assistant. Based on the question please provide appropriate answers |
1. Administration, Inhalation; 2. Adrenergic beta‐2 Receptor Antagonists [*administration & dosage]; 3. Asthma, Exercise‐Induced [*drug therapy]; 4. Bronchoconstriction; 5. Bronchodilator Agents [*administration & dosage]; 6. Forced Expiratory Volume [drug effects]; 7. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Beta2‐agonists for exercise‐induced asthma | You are a research assistant. Based on the question please provide appropriate answers |
1. Asthma [*rehabilitation]; 2. Exercise [*physiology]; 3. Health Status; 4. Physical Fitness [*physiology]; 5. Randomized Controlled Trials as Topic; 6. Respiratory Function Tests; | Provide MESH terms for the study
Physical training for asthma | You are a research assistant. Based on the question please provide appropriate answers |
1. *Nebulizers and Vaporizers; 2. Acute Disease; 3. Adrenergic beta‐Agonists [*administration & dosage]; 4. Anti‐Asthmatic Agents [*administration & dosage]; 5. Asthma [*drug therapy]; 6. Emergency Service, Hospital [statistics & numerical data]; 7. Equipment Design; 8. Inhalation Spacers [statistics & numerical data]; 9. Length of Stay [statistics & numerical data]; 10. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Holding chambers (spacers) versus nebulisers for beta‐agonist treatment of acute asthma | You are a research assistant. Based on the question please provide appropriate answers |
1. Asthma [*rehabilitation]; 2. Breathing Exercises [*methods]; 3. Muscle Strength [physiology]; 4. Randomized Controlled Trials as Topic; 5. Respiratory Muscles [*physiopathology]; 6. Respiratory Therapy [instrumentation, *methods]; | Provide MESH terms for the study
Inspiratory muscle training for asthma | You are a research assistant. Based on the question please provide appropriate answers |
1. Adrenal Cortex Hormones [*administration & dosage, adverse effects]; 2. Adrenergic beta‐2 Receptor Agonists [*administration & dosage, adverse effects]; 3. Albuterol [administration & dosage, adverse effects, analogs & derivatives]; 4. Androstadienes [administration & dosage, adverse effects]; 5. Bronchodilator Agents [administration & dosage, adverse effects]; 6. Budesonide [administration & dosage, adverse effects]; 7. Drug Combinations; 8. Drug Therapy, Combination [adverse effects, methods]; 9. Ethanolamines [administration & dosage, adverse effects]; 10. Fluticasone‐Salmeterol Drug Combination; 11. Formoterol Fumarate; 12. Nebulizers and Vaporizers; 13. Pneumonia [chemically induced]; 14. Pulmonary Disease, Chronic Obstructive [*drug therapy, mortality]; 15. Randomized Controlled Trials as Topic; 16. Steroids [*administration & dosage, adverse effects]; | Provide MESH terms for the study
Combined corticosteroid and long‐acting beta2‐agonist in one inhaler versus inhaled corticosteroids alone for chronic obstructive pulmonary disease | You are a research assistant. Based on the question please provide appropriate answers |
1. Administration, Inhalation; 2. Adrenergic beta‐2 Receptor Agonists [administration & dosage, *therapeutic use]; 3. Asthma [*drug therapy]; 4. Atropine [administration & dosage, therapeutic use]; 5. Cholinergic Antagonists [administration & dosage, *therapeutic use]; 6. Disease Progression; 7. Drug Therapy, Combination [methods]; 8. Hospitalization [statistics & numerical data]; 9. Ipratropium [administration & dosage, therapeutic use]; 10. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Combined inhaled anticholinergics and short‐acting beta2‐agonists for initial treatment of acute asthma in children | You are a research assistant. Based on the question please provide appropriate answers |
1. Acute Lung Injury [mortality, *therapy]; 2. Liquid Ventilation [*methods]; 3. Morbidity; 4. Randomized Controlled Trials as Topic; 5. Respiratory Distress Syndrome [mortality, *therapy]; | Provide MESH terms for the study
Partial liquid ventilation for preventing death and morbidity in adults with acute lung injury and acute respiratory distress syndrome | You are a research assistant. Based on the question please provide appropriate answers |
1. Administration, Inhalation; 2. Adrenergic beta‐2 Receptor Agonists [*administration & dosage]; 3. Albuterol [administration & dosage, *analogs & derivatives]; 4. Androstadienes [*administration & dosage]; 5. Bronchodilator Agents [*administration & dosage]; 6. Drug Therapy, Combination [methods]; 7. Fluticasone; 8. Patient Dropouts [statistics & numerical data]; 9. Pneumonia [drug therapy]; 10. Pulmonary Disease, Chronic Obstructive [*drug therapy, mortality]; 11. Salmeterol Xinafoate; 12. Scopolamine Derivatives [*administration & dosage]; 13. Tiotropium Bromide; | Provide MESH terms for the study
Combination inhaled steroid and long‐acting beta2‐agonist versus tiotropium for chronic obstructive pulmonary disease | You are a research assistant. Based on the question please provide appropriate answers |
1. Randomized Controlled Trials as Topic; 2. Sleep Apnea, Obstructive [*drug therapy]; | Provide MESH terms for the study
Drug therapy for obstructive sleep apnoea in adults | You are a research assistant. Based on the question please provide appropriate answers |
1. *Patient Education as Topic; 2. *Physician's Role; 3. *Smoking Cessation; 4. *Smoking Prevention; 5. Practice Patterns, Physicians'; 6. Randomized Controlled Trials as Topic; 7. Smoking [mortality]; 8. Treatment Outcome; | Provide MESH terms for the study
Physician advice for smoking cessation | You are a research assistant. Based on the question please provide appropriate answers |
1. Administration, Inhalation; 2. Adrenal Cortex Hormones [*administration & dosage]; 3. Anti‐Asthmatic Agents [*administration & dosage]; 4. Asthma [*drug therapy]; 5. Bronchodilator Agents [administration & dosage]; 6. Budesonide [*administration & dosage]; 7. Chronic Disease; 8. Drug Combinations; 9. Ethanolamines [*administration & dosage]; 10. Formoterol Fumarate; 11. Terbutaline [administration & dosage]; | Provide MESH terms for the study
Combination formoterol and budesonide as maintenance and reliever therapy versus current best practice (including inhaled steroid maintenance), for chronic asthma in adults and children | You are a research assistant. Based on the question please provide appropriate answers |
1. Asthma [physiopathology, *rehabilitation]; 2. Oxygen Consumption [physiology]; 3. Randomized Controlled Trials as Topic; 4. Respiratory Function Tests; 5. Swimming [*physiology]; 6. Time Factors; | Provide MESH terms for the study
Swimming training for asthma in children and adolescents aged 18 years and under | You are a research assistant. Based on the question please provide appropriate answers |
1. Acute Disease; 2. Administration, Inhalation; 3. Adrenal Cortex Hormones [*administration & dosage]; 4. Cough [*drug therapy]; 5. Treatment Outcome; | Provide MESH terms for the study
Inhaled corticosteroids for subacute cough in children | You are a research assistant. Based on the question please provide appropriate answers |
1. Acute Lung Injury [*mortality, therapy]; 2. Randomized Controlled Trials as Topic; 3. Respiration, Artificial [*methods, mortality]; 4. Respiratory Distress Syndrome [*mortality, therapy]; 5. Tidal Volume; | Provide MESH terms for the study
Lung protective ventilation strategy for the acute respiratory distress syndrome | You are a research assistant. Based on the question please provide appropriate answers |
1. Acute Lung Injury [complications, mortality, *therapy]; 2. Liquid Ventilation [*methods, mortality]; 3. Randomized Controlled Trials as Topic; 4. Respiratory Distress Syndrome [complications, mortality, *therapy]; 5. Respiratory Distress Syndrome, Newborn [complications, mortality, *therapy]; | Provide MESH terms for the study
Partial liquid ventilation for the prevention of mortality and morbidity in paediatric acute lung injury and acute respiratory distress syndrome | You are a research assistant. Based on the question please provide appropriate answers |
1. Adrenal Cortex Hormones [*administration & dosage, adverse effects]; 2. Androstadienes [administration & dosage, adverse effects]; 3. Anti‐Asthmatic Agents [*administration & dosage, adverse effects]; 4. Asthma [*drug therapy]; 5. Budesonide [administration & dosage, adverse effects]; 6. Fluticasone; 7. Pregnenediones [*administration & dosage, adverse effects]; 8. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Ciclesonide versus other inhaled corticosteroids for chronic asthma in children | You are a research assistant. Based on the question please provide appropriate answers |
1. Administration, Inhalation; 2. Adrenal Cortex Hormones [*administration & dosage]; 3. Anti‐Asthmatic Agents [*administration & dosage]; 4. Asthma [*drug therapy]; 5. Disease Progression; 6. Drug Administration Schedule; 7. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Intermittent versus daily inhaled corticosteroids for persistent asthma in children and adults | You are a research assistant. Based on the question please provide appropriate answers |
1. Activities of Daily Living; 2. *Antipsychotic Agents [adverse effects]; 3. Psychosocial Intervention; 4. Quality of Life; 5. Restraint, Physical; | Provide MESH terms for the study
Psychosocial interventions for reducing antipsychotic medication in care home residents | You are a research assistant. Based on the question please provide appropriate answers |
1. *Dementia [prevention & control]; 2. *Long-Term Care; 3. Nursing Homes; 4. Quality of Life; 5. Restraint, Physical; | Provide MESH terms for the study
Interventions for preventing and reducing the use of physical restraints for older people in all long‐term care settings | You are a research assistant. Based on the question please provide appropriate answers |
1. Aggression; 2. Anxiety; 3. *Cognitive Behavioral Therapy [methods]; 4. *Psychotic Disorders; 5. *Schizophrenia [complications, therapy]; | Provide MESH terms for the study
Cognitive behavioural therapy plus standard care versus standard care for persistent aggressive behaviour or agitation in people with schizophrenia | You are a research assistant. Based on the question please provide appropriate answers |
1. Activities of Daily Living; 2. *Alzheimer Disease; 3. Anxiety; 4. Cognitive Training; 5. *Dementia; | Provide MESH terms for the study
Cognitive rehabilitation for people with mild to moderate dementia | You are a research assistant. Based on the question please provide appropriate answers |
1. Affect; 2. Anxiety; 3. *Dementia [psychology]; 4. *Long-Term Care; 5. Quality of Life; 6. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Personally tailored activities for improving psychosocial outcomes for people with dementia in long‐term care | You are a research assistant. Based on the question please provide appropriate answers |
1. Cognition [*physiology]; 2. Dementia [*therapy]; 3. Memory [physiology]; 4. Orientation [*physiology]; 5. Psychotherapy [*methods]; 6. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Cognitive stimulation to improve cognitive functioning in people with dementia | You are a research assistant. Based on the question please provide appropriate answers |
1. Caregivers [psychology]; 2. *Dementia [complications]; 3. Quality of Life; 4. Randomized Controlled Trials as Topic; 5. *Sleep Wake Disorders [epidemiology, therapy]; | Provide MESH terms for the study
Non‐pharmacological interventions for sleep disturbances in people with dementia | You are a research assistant. Based on the question please provide appropriate answers |
1. Anticonvulsants [therapeutic use]; 2. Antidepressive Agents [therapeutic use]; 3. *Antipsychotic Agents [therapeutic use]; 4. *Gambling [drug therapy]; 5. Headache; 6. Naltrexone; 7. Narcotic Antagonists [therapeutic use]; 8. Nausea [drug therapy]; 9. Olanzapine; | Provide MESH terms for the study
Pharmacological interventions for the treatment of disordered and problem gambling | You are a research assistant. Based on the question please provide appropriate answers |
1. Emergency Service, Hospital; 2. Hospitalization; 3. *Hospitals, General; 4. Randomized Controlled Trials as Topic; 5. *Restraint, Physical; | Provide MESH terms for the study
Interventions for preventing and reducing the use of physical restraints of older people in general hospital settings | You are a research assistant. Based on the question please provide appropriate answers |
1. Aspirin [therapeutic use]; 2. *Cerebral Small Vessel Diseases [complications, diagnostic imaging, drug therapy]; 3. *Cognitive Dysfunction [drug therapy, prevention & control]; 4. *Dementia [prevention & control]; 5. Neuroimaging; 6. Platelet Aggregation Inhibitors [therapeutic use]; 7. *Stroke [diagnostic imaging, drug therapy, prevention & control]; | Provide MESH terms for the study
Antithrombotic therapy to prevent cognitive decline in people with small vessel disease on neuroimaging but without dementia | You are a research assistant. Based on the question please provide appropriate answers |
1. Algorithms; 2. *Dementia [complications, psychology]; 3. Nursing Homes; 4. *Pain Management [methods]; 5. Quality of Life; | Provide MESH terms for the study
Algorithm‐based pain management for people with dementia in nursing homes | You are a research assistant. Based on the question please provide appropriate answers |
1. Hydrocortisone [therapeutic use]; 2. Paroxetine; 3. Psychotherapy [methods]; 4. Quality of Life; 5. *Stress Disorders, Post-Traumatic [psychology]; | Provide MESH terms for the study
Early pharmacological interventions for universal prevention of post‐traumatic stress disorder (PTSD) | You are a research assistant. Based on the question please provide appropriate answers |
1. *Delirium [prevention & control]; 2. Hospitalization; 3. Incidence; 4. Inpatients; 5. *Medication Review; | Provide MESH terms for the study
Non‐pharmacological interventions for preventing delirium in hospitalised non‐ICU patients | You are a research assistant. Based on the question please provide appropriate answers |
1. Activities of Daily Living; 2. Cognition; 3. *Cognitive Dysfunction; 4. *Dementia [prevention & control]; 5. Quality of Life; | Provide MESH terms for the study
Multi‐domain interventions for the prevention of dementia and cognitive decline | You are a research assistant. Based on the question please provide appropriate answers |
1. *Bipolar Disorder [drug therapy]; 2. Depression [drug therapy]; 3. *Ketamine [therapeutic use]; 4. Quality of Life; 5. Receptors, Glutamate; | Provide MESH terms for the study
Ketamine and other glutamate receptor modulators for depression in adults with bipolar disorder | You are a research assistant. Based on the question please provide appropriate answers |
1. Anticonvulsants [therapeutic use]; 2. *Bipolar Disorder [drug therapy]; 3. Lamotrigine [adverse effects]; 4. Quality of Life; 5. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Lamotrigine in the maintenance treatment of bipolar disorder | You are a research assistant. Based on the question please provide appropriate answers |
1. Antidepressive Agents [therapeutic use]; 2. Depression; 3. *Depressive Disorder, Major [drug therapy]; 4. *Ketamine [therapeutic use]; 5. Receptors, Glutamate [therapeutic use]; | Provide MESH terms for the study
Ketamine and other glutamate receptor modulators for depression in adults with unipolar major depressive disorder | You are a research assistant. Based on the question please provide appropriate answers |
1. Caregivers; 2. Dementia [*complications]; 3. *Enteral Nutrition; 4. Gastrostomy; 5. Intubation, Gastrointestinal [adverse effects]; 6. Malnutrition [*prevention & control]; 7. Randomized Controlled Trials as Topic; 8. Treatment Outcome; | Provide MESH terms for the study
Enteral tube feeding for people with severe dementia | You are a research assistant. Based on the question please provide appropriate answers |
1. Antidepressive Agents [therapeutic use]; 2. Bias; 3. Cognition; 4. Depression [diagnosis, drug therapy, *therapy]; 5. Drug Resistance; 6. Electroconvulsive Therapy; 7. Magnetic Field Therapy [adverse effects, *methods]; 8. Quality of Life; 9. Randomized Controlled Trials as Topic; 10. Schizophrenia [therapy]; 11. Symptom Assessment; | Provide MESH terms for the study
Magnetic seizure therapy for treatment‐resistant depression | You are a research assistant. Based on the question please provide appropriate answers |
1. Alzheimer Disease [*prevention & control]; 2. Antihypertensive Agents [*therapeutic use]; 3. Cognition Disorders [*prevention & control]; 4. Dementia, Vascular [*prevention & control]; 5. Hypertension [complications, *drug therapy]; 6. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Pharmacological treatment of hypertension in people without prior cerebrovascular disease for the prevention of cognitive impairment and dementia | You are a research assistant. Based on the question please provide appropriate answers |
1. Antidepressive Agents [*therapeutic use]; 2. Anxiety Disorders [*drug therapy]; 3. Cognitive Behavioral Therapy; 4. Depression [*drug therapy]; 5. Drug Tapering; 6. Quality of Life; 7. Randomized Controlled Trials as Topic; 8. Recurrence; 9. Time Factors; 10. *Withholding Treatment; | Provide MESH terms for the study
Approaches for discontinuation versus continuation of long‐term antidepressant use for depressive and anxiety disorders in adults | You are a research assistant. Based on the question please provide appropriate answers |
1. Activities of Daily Living; 2. Bias; 3. Cholinesterase Inhibitors [*administration & dosage, adverse effects]; 4. Cognition [drug effects]; 5. Dementia, Vascular [*drug therapy]; 6. Donepezil [*administration & dosage, adverse effects]; 7. Galantamine [*administration & dosage, adverse effects]; 8. *Network Meta-Analysis; 9. Nootropic Agents [administration & dosage, adverse effects]; 10. Physical Functional Performance; 11. Placebos [therapeutic use]; 12. Randomized Controlled Trials as Topic; 13. Rivastigmine [*administration & dosage, adverse effects]; | Provide MESH terms for the study
Cholinesterase inhibitors for vascular dementia and other vascular cognitive impairments: a network meta‐analysis | You are a research assistant. Based on the question please provide appropriate answers |
1. Antidepressive Agents [adverse effects, *therapeutic use]; 2. Bias; 3. Depression, Postpartum [*drug therapy]; 4. Patient Dropouts [statistics & numerical data]; 5. Placebos [therapeutic use]; 6. Randomized Controlled Trials as Topic; 7. Selective Serotonin Reuptake Inhibitors [adverse effects, *therapeutic use]; 8. Treatment Outcome; | Provide MESH terms for the study
Antidepressant treatment for postnatal depression | You are a research assistant. Based on the question please provide appropriate answers |
1. Activities of Daily Living; 2. *Alzheimer Disease [drug therapy]; 3. Cholinesterase Inhibitors [adverse effects]; 4. *Dementia [chemically induced, drug therapy]; 5. Donepezil [adverse effects]; 6. Memantine [adverse effects]; 7. *Parkinson Disease [drug therapy]; 8. Quality of Life; 9. Rivastigmine [adverse effects]; | Provide MESH terms for the study
Withdrawal or continuation of cholinesterase inhibitors or memantine or both, in people with dementia | You are a research assistant. Based on the question please provide appropriate answers |
1. Antidepressive Agents [therapeutic use]; 2. *Antipsychotic Agents [therapeutic use]; 3. *Biological Products; 4. Randomized Controlled Trials as Topic; 5. *Self-Injurious Behavior [therapy]; 6. Systematic Reviews as Topic; | Provide MESH terms for the study
Pharmacological interventions for self‐harm in adults | You are a research assistant. Based on the question please provide appropriate answers |
1. Affect; 2. Bias; 3. Caregiver Burden [*prevention & control]; 4. Caregivers [*education, psychology]; 5. Dementia [*nursing]; 6. Family; 7. Health Services Accessibility [statistics & numerical data]; 8. Health Services Needs and Demand [statistics & numerical data]; 9. Institutionalization [statistics & numerical data]; 10. Nursing Homes [statistics & numerical data]; 11. Quality of Life; 12. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Remotely delivered information, training and support for informal caregivers of people with dementia | You are a research assistant. Based on the question please provide appropriate answers |
1. Caregivers [education, psychology]; 2. Cost of Illness; 3. Dementia [psychology, *rehabilitation]; 4. Depression [rehabilitation]; 5. *Independent Living; 6. Mental Status and Dementia Tests [statistics & numerical data]; 7. *Patient Preference; 8. Problem Behavior [psychology]; 9. Psychological Distress; 10. *Quality of Life; 11. Randomized Controlled Trials as Topic; 12. *Social Participation; 13. Spouses [education, psychology]; 14. Treatment Outcome; | Provide MESH terms for the study
Personally tailored activities for improving psychosocial outcomes for people with dementia in community settings | You are a research assistant. Based on the question please provide appropriate answers |
1. Behavior Therapy [*methods]; 2. Bias; 3. Breast Neoplasms [*psychology]; 4. Conflict of Interest; 5. Depression [*therapy]; 6. Noncommunicable Diseases [*psychology]; 7. Patient Acceptance of Health Care; 8. Problem Solving; 9. Randomized Controlled Trials as Topic; 10. Stroke [*psychology]; 11. Treatment Outcome; | Provide MESH terms for the study
Behavioural activation therapy for depression in adults with non‐communicable diseases | You are a research assistant. Based on the question please provide appropriate answers |
1. Anxiety [etiology]; 2. Bias; 3. Confidence Intervals; 4. Hallucinations [*therapy]; 5. Intention to Treat Analysis; 6. Mental Health; 7. Odds Ratio; 8. Patient Dropouts [psychology, statistics & numerical data]; 9. Psychotic Disorders [therapy]; 10. Quality of Life; 11. Randomized Controlled Trials as Topic; 12. Recurrence; 13. Schizophrenia [*therapy]; 14. Schizophrenic Psychology; 15. Therapies, Investigational [adverse effects, *methods]; 16. Therapy, Computer-Assisted [methods]; 17. Virtual Reality Exposure Therapy [*methods]; | Provide MESH terms for the study
Avatar Therapy for people with schizophrenia or related disorders | You are a research assistant. Based on the question please provide appropriate answers |
1. Activities of Daily Living; 2. Alzheimer Disease [epidemiology, prevention & control]; 3. Anti-Inflammatory Agents, Non-Steroidal [administration & dosage, adverse effects, *therapeutic use]; 4. Aspirin [administration & dosage, adverse effects, *therapeutic use]; 5. Celecoxib [administration & dosage, adverse effects, therapeutic use]; 6. Cyclooxygenase 2 Inhibitors [administration & dosage, adverse effects, therapeutic use]; 7. Dementia [epidemiology, mortality, *prevention & control]; 8. Hemorrhage [chemically induced, epidemiology]; 9. Incidence; 10. Lactones [therapeutic use]; 11. Myocardial Infarction [epidemiology]; 12. Naproxen [therapeutic use]; 13. Randomized Controlled Trials as Topic; 14. Stroke [epidemiology]; 15. Sulfones [therapeutic use]; | Provide MESH terms for the study
Aspirin and other non‐steroidal anti‐inflammatory drugs for the prevention of dementia | You are a research assistant. Based on the question please provide appropriate answers |
1. Dementia [psychology, *therapy]; 2. Depression [*therapy]; 3. *Family; 4. Psychomotor Agitation [*therapy]; 5. Randomized Controlled Trials as Topic; 6. *Tape Recording; 7. *Videotape Recording; | Provide MESH terms for the study
Simulated presence therapy for dementia | You are a research assistant. Based on the question please provide appropriate answers |
1. *Cognition; 2. Activities of Daily Living; 3. Cognitive Dysfunction [*prevention & control]; 4. Computer‐Assisted Instruction; 5. Healthy Aging; 6. Memory, Episodic; 7. Quality of Life; 8. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Computerised cognitive training for 12 or more weeks for maintaining cognitive function in cognitively healthy people in late life | You are a research assistant. Based on the question please provide appropriate answers |
1. Activities of Daily Living; 2. Cognitive Dysfunction [rehabilitation, *therapy]; 3. Dementia [rehabilitation, *therapy]; 4. Parkinson Disease [*psychology]; 5. Quality of Life; 6. Randomized Controlled Trials as Topic; 7. Task Performance and Analysis; | Provide MESH terms for the study
Cognitive training interventions for dementia and mild cognitive impairment in Parkinson’s disease | You are a research assistant. Based on the question please provide appropriate answers |
1. *Patient Care Team; 2. Activities of Daily Living; 3. Delirium [prevention & control]; 4. Dementia [*complications]; 5. Hip Fractures [*rehabilitation, surgery]; 6. Quality of Life; 7. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Enhanced rehabilitation and care models for adults with dementia following hip fracture surgery | You are a research assistant. Based on the question please provide appropriate answers |
1. *Cognitive Behavioral Therapy; 2. Hospitalization [statistics & numerical data]; 3. Mental Disorders [*therapy]; 4. Psychotherapy; 5. Randomized Controlled Trials as Topic; 6. Recurrence; 7. Substance‐Related Disorders [*therapy]; | Provide MESH terms for the study
Psychosocial interventions for people with both severe mental illness and substance misuse | You are a research assistant. Based on the question please provide appropriate answers |
1. *Cognitive Behavioral Therapy; 2. *Family Therapy; 3. Interpersonal Relations; 4. Marital Therapy; 5. Patient Dropouts [statistics & numerical data]; 6. Randomized Controlled Trials as Topic; 7. Stress Disorders, Post‐Traumatic [*therapy]; 8. Treatment Outcome; 9. Waiting Lists; | Provide MESH terms for the study
Couple and family therapies for post‐traumatic stress disorder (PTSD) | You are a research assistant. Based on the question please provide appropriate answers |
1. Cognitive Behavioral Therapy [*methods]; 2. Patient Dropouts [statistics & numerical data]; 3. Quality of Life; 4. Randomized Controlled Trials as Topic; 5. Stress Disorders, Post‐Traumatic [psychology, *therapy]; 6. Treatment Outcome; 7. Waiting Lists; | Provide MESH terms for the study
Present‐centered therapy (PCT) for post‐traumatic stress disorder (PTSD) in adults | You are a research assistant. Based on the question please provide appropriate answers |
1. Amino Acids [adverse effects, *therapeutic use]; 2. Cognition [drug effects]; 3. Cost of Illness; 4. Dementia, Vascular [*drug therapy, psychology]; 5. Nootropic Agents [*therapeutic use]; 6. Quality of Life; 7. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Cerebrolysin for vascular dementia | You are a research assistant. Based on the question please provide appropriate answers |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.